Výsledky vyhledávání - "Zafer E, Ozturk"

Akademický článek

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology

Autor: Alan D Irvine, Amy S Paller, Emma Guttman-Yassky, Eulalia Baselga, Marjolein de Bruin-Weller, Shyamalie Jayawardena, Annie Zhang, Paola Mina-Osorio, Elena Rizova, Zafer E Ozturk

Publikováno v: BMJ Open, Vol 10, Iss 3 (2020)

Introduction Atopic dermatitis (AD) is a chronic inflammatory skin disease often associated with atopic comorbidities and has significant impact on children and their families. There is a lack of robust and longitudinal long-term data on disease char

Externí odkaz: https://doaj.org/article/428dc7919a6144c788613f96ef9897ce

Zobrazit plný text záznamu

335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment

Autor: Joseph F Merola, Albert S Chiou, Emmanuel During, Antonio Costanzo, Peter Foley, Marius Ardeleanu, Jiangming Wu, Zafer E Ozturk

Publikováno v: British Journal of Dermatology. 188

Sleep disturbance is considered one of the most prevalent symptoms of atopic dermatitis (AD), and is associated with daytime sleepiness, anxiety and depression. In previous phase 3 trials, dupilumab treatment demonstrated significant improvement in o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a8264212f3d044b6c8bcbf228eca4292
https://doi.org/10.1093/bjd/ljac140.029

Zobrazit plný text záznamu

332 Improvement in symptoms of atopic dermatitis (AD) and AD-related quality of life with dupilumab treatment in adults: 24-week results of the DUPISTAD study

Autor: Joseph F Merola, Albert S Chiou, Emmanuel During, Antonio Costanzo, Peter Foley, Marius Ardeleanu, Jiangming Wu, Zafer E Ozturk

Publikováno v: British Journal of Dermatology. 188

Atopic dermatitis (AD) is a chronic disease characterized by sleep disturbance, associated with night-time itching and scratching, along with skin pain, resulting in daytime drowsiness, diminished daytime productivity and overall reduced quality of l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2acbef60f5526ac40f453204c3005e78
https://doi.org/10.1093/bjd/ljac140.027

Zobrazit plný text záznamu

Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy

Autor: Ana Giménez-Arnau, E. Rizova, Shyamalie Jayawardena, Tove Agner, Zafer E. Ozturk, Åke Svensson, Marius Ardeleanu, Annalisa Patrizi, Petr Arenberger, Laurent Eckert, Marie L A Schuttelaar, Marjolein S. de Bruin-Weller, Andrew Pink, Silvia Ferrucci, Audrey Nosbaum, Pierre Paul Roquet-Gravy

Publikováno v: Journal of dermatological treatment, 32(2), 164-173. Taylor & Francis Ltd
Bruin-Weller, M D, Pink, A E, Patrizi, A, Gimenez-Arnau, A M, Agner, T, Roquet-Gravy, P P, Ferrucci, S M, Arenberger, P, Svensson, A, Schuttelaar, M L A, Nosbaum, A, Jayawardena, S, Rizova, E, Ardeleanu, M, Eckert, L & Ozturk, Z E 2021, ' Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy : baseline characteristics of participants on the EUROSTAD prospective observational study ', Journal of Dermatological Treatment, vol. 32, no. 2, pp. 164-173 . https://doi.org/10.1080/09546634.2020.1866741

Background: Insights into the real-world treatment paradigm and long-term burden of atopic dermatitis (AD) are needed to inform clinical and health policy decisions.Methods: The prospective, observational EUROSTAD study enrolled adults with moderate-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c604dff4c01449442d87fe0491e8253
https://doi.org/10.1080/09546634.2020.1866741

Zobrazit plný text záznamu

Plný text ve formátu HTML

Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis:results from an open-label extension study

Autor: Meng Zhang, Brad Shumel, Faisal A. Khokhar, Zafer E. Ozturk, Lisa A. Beck, Diamant Thaçi, Mette Deleuran, Marjolein S. de Bruin-Weller, Zhen Chen

Publikováno v: Beck, L A, Thaçi, D, Deleuran, M, de Bruin-Weller, M, Chen, Z, Khokhar, F A, Zhang, M, Ozturk, Z E & Shumel, B 2022, ' Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis : results from an open-label extension study ', Journal of Dermatological Treatment, vol. 33, no. 3, pp. 1608-1616 . https://doi.org/10.1080/09546634.2020.1871463

BACKGROUND: Most systemic agents used for moderate-to-severe atopic dermatitis (AD) may lead to adverse events requiring routine laboratory monitoring, increasing patient burden and possibly decreasing treatment adherence.OBJECTIVE: To evaluate clini

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c67e84b9721182b828b18a88e61ee9b
https://pure.au.dk/portal/da/publications/laboratory-safety-of-dupilumab-for-up-to-3-years-in-adults-with-moderatetosevere-atopic-dermatitis(7fe39251-db3f-47a2-9c82-30d768712c56).html

Zobrazit plný text záznamu

Akademický článek

Effect of zoledronic acid on serum calcium in Paget’s disease patients after educational strategies to improve calcium and vitamin D supplementation

Autor: Joseph R. Tucci, Henry G. Bone, Guoqin Su, Monique Tan, Zafer E. Ozturk, Paul Aftring

Publikováno v: Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)

Objective: Bisphosphonates are the most effective therapeutic agents in patients with Paget’s disease of bone. As a result of their inhibition of osteoclastic activity, hypocalcemia of variable frequency and severity following intravenous bisphosph

Externí odkaz: https://doaj.org/article/a912212faf3d4c18a488ffd8686b5aa7

Zobrazit plný text záznamu

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology

Autor: A.D. Irvine, Eulalia Baselga, Marjolein S. de Bruin-Weller, Paola Mina-Osorio, Emma Guttman-Yassky, E. Rizova, Zafer E. Ozturk, Amy S. Paller, Shyamalie Jayawardena, Annie Zhang

Publikováno v: BMJ Open
BMJ Open, Vol 10, Iss 3 (2020)

IntroductionAtopic dermatitis (AD) is a chronic inflammatory skin disease often associated with atopic comorbidities and has significant impact on children and their families. There is a lack of robust and longitudinal long-term data on disease chara

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2f895018d45ec9397e71f3b66a08e21
https://pubmed.ncbi.nlm.nih.gov/32209624

Zobrazit plný text záznamu

Effect of zoledronic acid on serum calcium in Paget's disease patients after educational strategies to improve calcium and vitamin D supplementation

Autor: R. Paul Aftring, Monique Tan, Joseph R. Tucci, Henry G. Bone, Guoqin Su, Zafer E. Ozturk

Publikováno v: Therapeutic Advances in Endocrinology and Metabolism, Vol 6 (2015)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d97bf0868d207b462805b2eb7d74c2b2
https://pubmed.ncbi.nlm.nih.gov/26301065

Zobrazit plný text záznamu

Treatment Patterns and Costs for Anti-TNFα Therapy in Patients with Ankylosing Spondylitis

Autor: Vivian Herrera, Y. Tsang, Zafer E. Ozturk, Yunfeng Li, Jacqueline B. Palmer, Minlei Liao

Publikováno v: Rheumatology: Current Research.

Objective: Limited information exists on real-world use of anti-tumor necrosis factor-α (TNFα) biologic agents in ankylosing spondylitis (AS). This study evaluated the treatment patterns and costs of anti-TNFα biologic therapy and disease-modifyin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8c347655c3d02ce3f2f1a2d8c26c6dcf
https://doi.org/10.4172/2161-1149.s6-007

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání